Navigation Links
Express Scripts to Present at Investor Conferences in March
Date:2/22/2011

ST. LOUIS, Feb. 22, 2011 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the following conferences in March:

2011 Citi Global Healthcare Conference on March 3, 2011 at 10:30 a.m. EST at the New York Hilton in New York, NY.

2011 Barclays Capital Global Healthcare Conference on March 16, 2011 at 8:00 a.m. EDT at the Lowes Miami Hotel in Miami, FL

These presentations will also be broadcast via the Internet and can be accessed on the investor relations section of Express Scripts web site at http://www.express-scripts.com.  RealPlayer or Windows Media Player is needed to listen to the Webcasts and free downloads of these players are available at the Webcast site. The Webcasts will be archived and available for replay for 14 days.

Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/


'/>"/>
SOURCE Express Scripts, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Announcement - Clontech Laboratories, Inc. Releases the Tet-Express™ Inducible Expression System
2. Pfenex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the Use of Pfenex Expression Technology™
3. De Novo Software Launches New Version of FCS Express for Flow and Image Cytometry
4. Express Scripts to Present at the J.P. Morgan Healthcare Conference
5. Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus
6. Express Scripts Establishes Industrys Most Comprehensive Specialty Benefits Organization; Enhances Patient Care and Guarantees Cost Savings
7. Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance
8. Express Scripts to Present at Investor Conferences in November
9. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
10. NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, The Directors Common Fund to Provide Human Tissue for GTEx, the New Genotype-Tissue Expression Project
11. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
(Date:5/23/2013)... May 23, 2013  Texas, premier physician associations today ... the survival tools they need to provide demonstrably better ... health care marketplace. "I am confident the ... practices," said Stephen L. Brotherton , ... Texas doctors are determined to make ...
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress ... telemedicine market, announced today the company has signed a ... staffing company based in Huntsville, AL ... specializes in the staffing and recruitment of telemedicine physicians. ... of the final agreement, which is expected by June ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... state,are invited to help advance research in women,s ... The registry, created by the Institute,for Women,s Health ... developed to encourage researchers to focus on women,s ... the chance to be part of,university-sponsored research studies ...
... 13 Raven,biotechnologies, inc., a privately held company ... therapeutics (MAbs) for cancer,today announced that it has ... lead,clinical product, in combination with gemcitabine in the ... Phase 2 Pancreatic Cancer Study will be conducted ...
Cached Medicine Technology:Women Invited to Join New Health Registry to Advance Research 2Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 2Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3
(Date:5/24/2013)... (PRWEB) May 24, 2013 The ... of products used outside the central laboratory, by ... a healthcare practitioner or by consumers. This includes ... fertility and pregnancy, infectious and cardiovascular disease and ... such as critical care, surgical and emergency departments. ...
(Date:5/24/2013)... of its kind, Impacts World 2013 from May ... from politics, business and civil society to discuss ... research across sectors and scales. , Webcast of ... May 27th, 1pm to 1:55pm and opening plenary ... include: , Connie Hedegaard, EU Commissioner for ...
(Date:5/24/2013)... research presented today shows that formation of new neurons ... its importance in learning and remembering - could cause ... existing brain circuits. Drs. Paul Frankland and Sheena ... Toronto, argue this reorganization could have the positive effect ... capacity for new learning. These results were presented ...
(Date:5/24/2013)... The creative flair and design talent ... (PolyU)'s Institute of Textiles and Clothing (ITC) have won ... Show held on 22 May at The Mira Hong ... ITC design students, various knitwear producers and yarn suppliers, ... of four outfits from 20 graduating students majoring in ...
(Date:5/24/2013)... -- Nearly three out of four pregnant women ... but these issues don,t significantly affect their quality ... from Loyola University Medical Center in Maywood, Ill., ... physiological and hormonal changes that occur during pregnancy. ... can play a role. The study authors added ...
Breaking Medicine News(10 mins):Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2Health News:PolyU Stages Knitwear Fashion Show 2Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2
... MD The Endocrine Society,s 91st Annual Meeting, ENDO 09 ... Center in Washington, DC, June 10-13, 2009. Approximately 7,500 ... expected to assemble for this premier meeting of hormone ... an opportunity for journalists to learn about the latest ...
... possible, transplanting stem cells from the patient,s own bone marrow is ... , The procedure has been tested successfully in the ... shown in 80% of cases, and considerable improvement in quality of ... Clnic has used this therapy in a total of 6 patients. ...
... RiskAnalyzer Incorporates Johns Hopkins ACG System for Provider ... Ala., Feb. 19 ... its new Medicare risk adjustment software, DSTHS RiskAnalyzer(TM). ... coding is not capturing disease conditions under the ...
... hospital clients received unexpected checks totaling nearly $4.4 ... from $65,000 to more than $750,000 - were ... unique and innovative partnership between the hospital management ... the QHR/Gallagher Retro Insurance Program, hospital groups that ...
... correlate relationship with the invasion and metastasis of ... N-cadherin may promote motility and invasion in carcinoma ... and N-cadherin expressions in esophageal squamous cell carcinoma ... Fan from China detected the expression of E-cadherin ...
... Roughly 100,000 Swedes are under treatment with the blood-thinning ... which makes the initiation of treatment a risky balancing ... at Uppsala University have developed a model for calculating ... appears in the scientific publication New England Journal ...
Cached Medicine News:Health News:News media registration opens for ENDO 09 in Washington, D.C. 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 2Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 3Health News:QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospital Clients 2Health News:Knowledge of genetics improves uncertain medication 2
... the sounds you need to ... other body sounds while reducing ... Littmann Model 3000., ,With Ambient ... to 18 times amplification, and ...
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
... control material used for monitoring the performance of ... for specific use on Bayer analyzers that measure ... 270) and the AVOX Systems CO-Oximeters (4000 and ... the IRMA TRUpoint. CC 527 is available in ...
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....
Medicine Products: